top of page
CRAMbridge blog is our musings on the state of healthcare, pharmaceuticals, eLearning, start-ups, and everything in between.
Latest blog entries are below.
The hype vs reality of VR enabled learning in pharma and biotech
Pandemic induced workplace disruptions have been keenly felt in employee training across pharmaceutical and biotech enterprises. Starting...
A leading voice in biopharma quality joins CRAMbridge.
Swapnil Ballal Swapnil Ballal, a quality and processes leader in India’s pharma and biopharma sectors has joined CRAMbridge as partner,...
Fire diamonds and workplace safety
The NFPA “fire diamond” is a recognized tool to help keep safety in labs. This Crambridge micro nugget introduces the fire diamond in...
Training for compliance vs. Training to think
While you read this article, about 60 deviations will be logged within global GMP environments*. Half of them would have been caused by...
MicroNuggets: efficient counterbalance to long, drawn-out, learning modules
What are learning MicroNuggets? Learning modules frequently try to do too much. They end up being long-winded and laborious, and run the...
Why do so many Indian startups seem to be founded by North Indian dudes?
Something jumped out at me in Yourstory magazine’s list of top 100 Indian startups and their founders. There seemed to be more Agarwals,...
Quality training as the anti-Jugaad
Is India really running pharma and biotech sweatshops? India is the market leader in high quality generic medicine. The drugs that people...
Fresh Biotech grads in India are being set up for an epic fail
One of the things I enjoy most is interacting with recent biotech graduates. I still remember how lost I was when I got out of college....
Want to increase your chances of start-up success? Lack focus.
I recently had an industry watcher tell me that the key ingredient to a start-up’s success is focus. You need to be focused like a laser...
How one start-up caused a 4% drop in biotech stocks in a single day.
Lost in the recent Volkswagen mayhem is the carnage in Biotech based holdings. The iShares NASDAQ biotech index is down about 5% in the...
The fallacy of “protecting your turf”
I’ve been getting Indian CROs on CRAMbridge over the last couple of weeks and am amazed by the breadth and depth of scientific talent...
The one entrepreneur + VC story every biotech start-up should have in its DNA
The birth of the first biotech startup The mid-70s was to biotechnology what the late 60s was to rock music (except no one knew that’s...
bottom of page